Pamela Davis

Featured in: Favicon

wiley.com

nature.com Favicon

jamanetwork.com Favicon

patch.com

sheknows.com Favicon

thelancet.com Favicon

santacruzsentinel.com Favicon

mondaq.com Favicon

nonprofitquarterly.org Favicon

appliedclinicaltrialsonline.com + 5 more

Articles

Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder

Jul 30, 2024 | jamanetwork.com | william wang |Nora D. Volkow |Nathan A Berger |Pamela Davis

Introduction Drug overdose fatalities in the United States remain high, with an estimated 107 543 deaths in 2023, mostly from opioids.1 Despite the effectiveness of medications for opioid use disorder (OUD) in preventing overdoses, only an estimated 25% of individuals with OUD receive them,2 and close to 50% discontinue treatment within 6 months. There is an urgency for alternative treatments for OUD.
Author Correction: Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population - Nature Communications

Jun 18, 2024 | nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber

Correction to: Nature Communications https://doi.org/10.1038/s41467-024-48780-6, published online 28 May 2024In this article in the abstract the word clinical was misspelt as clinicl.
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population - Nature Communications

May 27, 2024 | nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber

AbstractAlcohol use disorders are among the top causes of the global burden of disease, yet therapeutic interventions are limited. Reduced desire to drink in patients treated with semaglutide has raised interest regarding its potential therapeutic benefits for alcohol use disorders.
Association of semaglutide with risk of suicidal ideation in a real-world cohort - Nature Medicine

Jan 5, 2024 | nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber

AbstractConcerns over reports of suicidal ideation associated with semaglutide treatment, a glucagon-like peptide 1 receptor (GLP1R) agonist medication for type 2 diabetes (T2DM) and obesity, has led to investigations by European regulatory agencies. In this retrospective cohort study of electronic health records from the TriNetX Analytics Network, we aimed to assess the associations of semaglutide with suicidal ideation compared to non-GLP1R agonist anti-obesity or anti-diabetes medications.
"We need to get exposed so we build immunity"

Dec 27, 2023 | youhavetoliveyour.life | Hayley Gleeson |Lindsey Wang |Pamela Davis |Nathan A Berger

Australian Broadcasting Corporation Other / Mixed Journalist Study Other / Mixed Article on a study Journalist Article on a study Journalist Other / Mixed Group of professionals Study Other / Mixed Johns Hopkins Bloomberg School of Public Health Other / Mixed Other / Mixed University of Auckland News and Opinion Article on a study Other / Professional Article on a study Other / Mixed...
Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States - npj Vaccines

Nov 22, 2023 | nature.com | Pamela Davis |David C. Kaelber

AbstractThe Centers for Disease Control and Prevention announced in January 2023 a potential connection between administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS). A retrospective cohort study was conducted to compare the hazard of IS in patients aged 65 years and over administered the Pfizer bivalent booster versus those administered the Pfizer/Moderna monovalent or Moderna bivalent boosters.
Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study | Family Medicine and Community Health

Oct 1, 2023 | fmch.bmj.com | Lindsey Wang |Pamela Davis |Nathan E. Berger |David C. Kaelber

Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort study Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder

Aug 16, 2023 | onlinelibrary.wiley.com | Lindsey Wang |Nora D. Volkow |Nathan A Berger |Pamela Davis

1 INTRODUCTION More than 109,000 Americans died of drug overdose in 2022, with 81,231 overdose deaths involving opioids (The Centers for Disease Control and Prevention—Vital Statistics Rapid Release - Provisional Drug Overdose Data, 2023). Methadone, buprenorphine and naltrexone are the most widely used medications for opioid use disorders (MOUD) and the most effective intervention for preventing overdose deaths (Volkow, 2021; Volkow & Blanco, 2021; Volkow et al., 2014).
Disrupted seasonality and association of COVID-19 with medically attended respiratory syncytial virus infections among young children in the US: January 2010-January 2023 | medRxiv

May 16, 2023 | medrxiv.org | Lindsey Wang |Pamela Davis |Nathan A Berger |David C. Kaelber

AbstractRespiratory syncytial virus (RSV) infections and hospitalizations surged sharply in 2022 among young children. To assess whether COVID-19 contributed to this surge, we leveraged a real-time nation-wide US database of electronic health records (EHRs) using time series analysis from January 1, 2010 through January 31, 2023, and propensity-score matched cohort comparisons for children aged 0–5 years with or without prior COVID-19 infection.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Pamela Davis

Articles

Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder

Author Correction: Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population - Nature Communications

Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population - Nature Communications

Association of semaglutide with risk of suicidal ideation in a real-world cohort - Nature Medicine

"We need to get exposed so we build immunity"

Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States - npj Vaccines

Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study | Family Medicine and Community Health

Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder

Disrupted seasonality and association of COVID-19 with medically attended respiratory syncytial virus infections among young children in the US: January 2010-January 2023 | medRxiv

Contact details

Emails

Socials & Sites